Christian Sturesson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Christian Sturesson has a total of 300 co-authors. Here are the top co-authors by number of shared publications:
Ernesto Sparrelid
Division of Surgery and Oncology, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Karolinska University Hospital , Stockholm
8 shared publicationsGert Lindell
Department of Surgery, Skåne University Hospital, Lund, Sweden
8 shared publicationsStefan Gilg
Division of Surgery and Oncology, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
7 shared publications- Jan Nilsson
Department of Clinical Sciences, Lund, Surgery, Lund University, Skåne University Hospital, Lund, Sweden
6 shared publications - Sam Eriksson
Surgery, Department of Clinical Sciences Lund, Lund University, Skåne University Hospital, Lund, Sweden
6 shared publications - Valentinus T. Valdimarsson
Department of Clinical Sciences Lund, Surgery, Lund University, Skane University Hospital, Lund, Sweden
6 shared publications
Latest Publications
- Open Access
- 3 November 2026
- Published by Oxford University Press (OUP) in BJS Open
- Vol. 10 (6)
Adult choledochal cyst resection in Scandinavia: uncommon malignancy and considerable morbidity in a multicentre surgical cohort
- 3 November 2026
- Published by Oxford University Press (OUP) in BJS Open
- Vol. 10 (6)
Open AccessAdult choledochal cyst resection in Scandinavia: uncommon malignancy and considerable morbidity in a multicentre surgical cohort
- Open Access
- 18 May 2026
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 52 (7) , 111884
Propensity matched comparison between one-stage and two-stage hepatectomy after portal vein embolization for bilateral colorectal liver metastases
- 18 May 2026
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 52 (7) , 111884
Open AccessPropensity matched comparison between one-stage and two-stage hepatectomy after portal vein embolization for bilateral colorectal liver metastases
- 30 October 2025
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 52 (1) , 111159
Assessing surgical resection in recurrent biliary tract cancer: International two-centre experience
- 30 October 2025
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 52 (1) , 111159
Assessing surgical resection in recurrent biliary tract cancer: International two-centre experience
- 28 March 2025
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 112 (4)
Preoperative management and resectability criteria in perihilar cholangiocarcinoma
- 28 March 2025
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 112 (4)
Preoperative management and resectability criteria in perihilar cholangiocarcinoma
- Open Access
- 22 March 2025
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 51 (7) , 109995
Hyperbilirubinemia does not impair induced liver hypertrophy after portal vein Embolization—a retrospective scandinavian cohort study
- 22 March 2025
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 51 (7) , 109995
Open AccessHyperbilirubinemia does not impair induced liver hypertrophy after portal vein Embolization—a retrospective scandinavian cohort study
- Open Access
- 5 March 2025
- Published by Oxford University Press (OUP) in BJS Open
- Vol. 10 (2)
Clinical implications of an intraoperative margin-positive distal bile duct in perihilar cholangiocarcinoma: international multicentre cohort study
The short- and long-term outcomes of intraoperative extension of the distal bile duct margin following a positive frozen section in patients with perihilar cholangiocarcinoma remain poorly characterized. Between 1 January 2003 and 1 January 2023, consecutive patients at seven high-volume European hepatopancreatobiliary centres undergoing major hepatectomy for perihilar cholangiocarcinoma with frozen-section analysis of the distal bile duct and subsequent intraoperative management were included retrospectively. The primary endpoint was achievement of an overall R0 resection following distal bile duct re-resection or additional pancreatoduodenectomy after identification of a positive distal bile duct frozen section. Secondary endpoints included overall survival, disease-free survival, and major postoperative complications (Clavien–Dindo grade ≥ IIIa). Outcomes were reported as adjusted hazard ratios. Of 785 patients undergoing major hepatectomy for perihilar cholangiocarcinoma, 594 underwent distal bile duct frozen-section analysis. A total of 66 (11.1%) intraoperative frozen sections were positive for invasive carcinoma, with an additional 7 (1.2%) false-negative findings. Distal bile duct re-resection was performed in 49 patients (74%), and 11 (16%) underwent additional pancreatoduodenectomy. Among these, 46 patients (69%) achieved distal bile duct margin clearance, with 30 (45%) ultimately attaining overall R0 resection. Overall survival was similar for patients who achieved overall R0 status via distal bile duct re-resection or pancreatoduodenectomy and those with overall R0 margins after primary negative distal bile duct frozen section (adjusted hazard ratio 0.84, 95% confidence interval 0.49 to 1.44; P = 0.536). Conversely, overall R1 resection was associated with significantly worse overall survival (adjusted hazard ratio 1.82, 1.43 to 2.33; P < 0.001). Complications graded ≥ IIIa and 90-day mortality did not differ significantly between groups undergoing distal bile duct re-resection, pancreatoduodenectomy or no intervention (P = 0.126 and P = 0.121, respectively). In selected patients, re-resection or additional pancreatoduodenectomy after positive distal bile duct frozen-section analysis is associated with long-term survival without significantly increasing major morbidity or mortality.
- 5 March 2025
- Published by Oxford University Press (OUP) in BJS Open
- Vol. 10 (2)
Open AccessClinical implications of an intraoperative margin-positive distal bile duct in perihilar cholangiocarcinoma: international multicentre cohort study
The short- and long-term outcomes of intraoperative extension of the distal bile duct margin following a positive frozen section in patients with perihilar cholangiocarcinoma remain poorly characterized. Between 1 January 2003 and 1 January 2023, consecutive patients at seven high-volume European hepatopancreatobiliary centres undergoing major hepatectomy for perihilar cholangiocarcinoma with frozen-section analysis of the distal bile duct and subsequent intraoperative management were included retrospectively. The primary endpoint was achievement of an overall R0 resection following distal bile duct re-resection or additional pancreatoduodenectomy after identification of a positive distal bile duct frozen section. Secondary endpoints included overall survival, disease-free survival, and major postoperative complications (Clavien–Dindo grade ≥ IIIa). Outcomes were reported as adjusted hazard ratios. Of 785 patients undergoing major hepatectomy for perihilar cholangiocarcinoma, 594 underwent distal bile duct frozen-section analysis. A total of 66 (11.1%) intraoperative frozen sections were positive for invasive carcinoma, with an additional 7 (1.2%) false-negative findings. Distal bile duct re-resection was performed in 49 patients (74%), and 11 (16%) underwent additional pancreatoduodenectomy. Among these, 46 patients (69%) achieved distal bile duct margin clearance, with 30 (45%) ultimately attaining overall R0 resection. Overall survival was similar for patients who achieved overall R0 status via distal bile duct re-resection or pancreatoduodenectomy and those with overall R0 margins after primary negative distal bile duct frozen section (adjusted hazard ratio 0.84, 95% confidence interval 0.49 to 1.44; P = 0.536). Conversely, overall R1 resection was associated with significantly worse overall survival (adjusted hazard ratio 1.82, 1.43 to 2.33; P < 0.001). Complications graded ≥ IIIa and 90-day mortality did not differ significantly between groups undergoing distal bile duct re-resection, pancreatoduodenectomy or no intervention (P = 0.126 and P = 0.121, respectively). In selected patients, re-resection or additional pancreatoduodenectomy after positive distal bile duct frozen-section analysis is associated with long-term survival without significantly increasing major morbidity or mortality.
- Open Access
- 30 December 2024
- Published by Oxford University Press (OUP) in BJS Open
- Vol. 9 (1)
Robotic-assisted contra open resection for suspected or confirmed gallbladder cancer (ROBOCOP)
- 30 December 2024
- Published by Oxford University Press (OUP) in BJS Open
- Vol. 9 (1)
Open AccessRobotic-assisted contra open resection for suspected or confirmed gallbladder cancer (ROBOCOP)